Ultraprocessed Foods & Brain Health: The Gut-Brain Research

The NOVA Classification: What Makes Food Ultraprocessed?

• NOVA Group 1 — Unprocessed or minimally processed: Whole foods in natural form — fresh fruits, vegetables, meat, fish, eggs, legumes, nuts, plain yogurt, unseasoned grains. Minimal alteration from their natural state
• NOVA Group 2 — Processed culinary ingredients: Substances extracted from natural foods used in cooking — oils, butter, flour, sugar, salt, vinegar. Not typically eaten alone
• NOVA Group 3 — Processed foods: Foods made by combining Group 1 and 2 ingredients — canned fish, cured meats, artisan cheese, fresh bread, simple packaged nuts. Recognisable as food
• NOVA Group 4 — Ultraprocessed foods: Industrial formulations containing ingredients rarely found in home kitchens — modified starches, hydrolyzed protein, high-fructose corn syrup, maltodextrin, artificial colors, flavors, emulsifiers (carboxymethylcellulose, polysorbate 80), stabilizers, humectants. Examples: packaged chips, soft drinks, breakfast cereals, instant noodles, flavored yogurts, reconstituted meat products, most fast food, packaged breads
• Scale of consumption: UPFs account for 57-60% of daily caloric intake in the US and UK, 50% in Canada, 45-50% in Australia. In low-income households, UPF consumption often exceeds 70% of calories. This is the dominant dietary pattern of modern high-income societies
• Why UPFs are different: UPFs are not simply "processed" foods — they are formulated to maximize palatability, shelf life, and profit. They are typically energy-dense, nutrient-poor, highly palatable, and engineered to override normal satiety signalling

The Gut-Brain Axis: Primary Pathway to the Brain

• The gut-brain connection: The gut and brain communicate bidirectionally via the vagus nerve, enteric nervous system, immune signalling, and microbial metabolites. Gut bacteria produce approximately 90% of the body's serotonin, 50% of its dopamine precursors, and significant quantities of GABA — all critical neurotransmitters for mood and cognition
• UPF additives and microbiome disruption: Emulsifiers (carboxymethylcellulose, polysorbate 80) used in many UPFs to improve texture and shelf life have been shown in mouse models to disrupt the mucus layer of the gut, promoting bacterial translocation across the epithelium and altering microbiome composition toward a more pro-inflammatory profile. Human data is emerging but mechanistically compelling
• Artificial sweeteners: Non-caloric sweeteners (saccharin, sucralose, aspartame) — ubiquitous in diet beverages and "sugar-free" UPFs — alter gut microbiome composition in human RCTs (Suez et al., 2022, Cell), impairing glucose tolerance in some individuals and reducing beneficial bacteria diversity
• Reduced microbiome diversity: UPF-heavy diets are associated with significantly lower gut microbial diversity — the single most consistent marker of gut health. Low diversity is associated with depression, cognitive impairment, obesity, inflammatory disease, and reduced immune resilience
• Tryptophan and serotonin: Dietary tryptophan (from protein) is the precursor to serotonin — 95% of which is produced in the gut. UPF-driven microbiome disruption impairs the microbial conversion of tryptophan to serotonin precursors, potentially reducing central serotonin availability and contributing to depression risk

Neuroinflammation: UPFs and the Brain's Immune System

• From gut to brain inflammation: UPF-driven gut dysbiosis and intestinal permeability increases systemic lipopolysaccharide (LPS) levels — a form of metabolic endotoxemia. LPS and pro-inflammatory cytokines (IL-6, TNF-alpha, IL-1beta) cross the blood-brain barrier via transport proteins and circumventricular organs, activating microglia (the brain's resident immune cells)
• Microglial activation and depression: Activated microglia produce neuroinflammatory mediators including prostaglandin E2, IDO (indoleamine 2,3-dioxygenase — which diverts tryptophan away from serotonin synthesis toward kynurenine), and reactive oxygen species. This neuroinflammatory state is increasingly recognized as a primary mechanism in treatment-resistant depression, not merely a consequence
• CRP and depression: Elevated CRP (above 1 mg/L) is significantly associated with depression risk and worse antidepressant treatment outcomes. UPF-heavy diets consistently elevate CRP. Anti-inflammatory dietary interventions reduce CRP and show antidepressant effects in RCTs
• Neurodegeneration: Chronic neuroinflammation is a key driver of Alzheimer's and Parkinson's disease pathology. UPF-associated metabolic syndrome, insulin resistance, and neuroinflammation collectively constitute the major modifiable risk pathway for late-life neurodegeneration
• SMILES trial (2017): Landmark RCT (n=67) found that switching to a Mediterranean-style diet for 12 weeks reduced depression scores significantly more than social support — with 32% of dietary intervention group achieving remission vs 8% of control. Dietary quality directly affects mood through the mechanisms described above

Cognitive Decline & Dementia

• ELSA-Brasil cohort (2022): Study of 10,775 Brazilian civil servants found each 10% increase in UPF consumption was associated with significantly accelerated decline in global cognitive function and executive function over 8 years — even after adjusting for socioeconomic status, overall caloric intake, and baseline health
• UK Biobank analysis (2023): Analysis of 72,083 participants found high UPF consumption associated with 25% higher dementia risk and 14% higher Alzheimer's disease risk — with each 10% increase in UPF consumption associated with progressive risk increase
• Type 3 diabetes hypothesis: Insulin resistance in the brain — driven by chronic hyperinsulinemia from high refined carbohydrate diets — impairs neuronal glucose metabolism, reduces BDNF (brain-derived neurotrophic factor), and promotes amyloid-beta accumulation. Some researchers refer to Alzheimer's disease as "type 3 diabetes" given these mechanistic overlaps
• BDNF suppression: Brain-derived neurotrophic factor — essential for neuronal survival, plasticity, and memory formation — is significantly reduced by high-fat, high-sugar diets and elevated by exercise and anti-inflammatory dietary patterns. UPF-heavy diets consistently suppress BDNF in animal models and are associated with lower BDNF in human observational studies
• Cognitive reserve: Lifelong dietary quality appears to contribute to cognitive reserve — the brain's resilience to age-related damage. Mediterranean dietary adherence is associated with larger brain volume, thicker cortex, and greater cognitive reserve in aging studies

The Neuroscience of UPF Addiction

• Hyperpalatable engineering: UPFs are specifically formulated to hit "bliss points" — optimal combinations of sugar, fat, salt, and texture that maximize palatability and consumption. These combinations produce dopamine responses in the nucleus accumbens (reward centre) that are not seen with whole foods
• Yale Food Addiction Scale: Using addiction criteria adapted from substance use disorders, approximately 14-20% of adults show food addiction patterns — characterized by loss of control, continued consumption despite negative consequences, and withdrawal-like symptoms. UPFs — particularly those high in sugar and fat combined — score highest on food addiction scales
• Eating rate and satiety: UPFs are typically soft, quickly eaten, and low in fibre — reducing chewing time and accelerating eating rate. Satiety hormones (PYY, GLP-1) are partially triggered by chewing and gastric stretch — both of which are attenuated by UPF consumption, allowing overconsumption before fullness signals arrive
• Habit formation: Repeated consumption of hyperpalatable UPFs reinforces neurological eating habits through dopaminergic habit learning — making it physiologically difficult to change dietary patterns even with conscious motivation. This neurological dimension distinguishes UPF overconsumption from simple lack of willpower

Practical Guidance: Reducing UPF Consumption

Frequently Asked Questions

References

1. 1.Monteiro CA, Cannon G, Levy RB, et al. (2019). Ultra-processed foods: what they are and how to identify them. Public Health Nutrition, 22(5), 936-941. doi:10.1017/S1368980018003762 PMID:30744710
2. 2.Jacka FN, O'Neil A, Opie R, et al. (2017). A randomised controlled trial of dietary improvement for adults with major depression (the SMILES trial). BMC Medicine, 15(1), 23. doi:10.1186/s12916-017-0791-y PMID:28137247
3. 3.Cryan JF, O'Riordan KJ, Cowan CSM, et al. (2019). The microbiota-gut-brain axis. Physiological Reviews, 99(4), 1877-2013. doi:10.1152/physrev.00018.2018 PMID:31460832
4. 4.Suez J, Cohen Y, Valdes-Mas R, et al. (2022). Personalized microbiome-driven effects of non-nutritive sweeteners on human glucose tolerance. Cell, 185(18), 3307-3328. doi:10.1016/j.cell.2022.07.016 PMID:36027589
5. 5.Chazelas E, Srour B, Desmetz E, et al. (2019). Sugary drink consumption and risk of cancer: results from NutriNet-Sante prospective cohort. BMJ, 366, l2408. doi:10.1136/bmj.l2408 PMID:31292122
6. 6.Zinöcker MK, Lindseth IA. (2018). The Western diet-microbiome-host interaction and its role in metabolic disease. Nutrients, 10(3), 365. doi:10.3390/nu10030365 PMID:29562591
7. 7.Juul F, Kim H, Mendez MA, et al. (2021). Ultra-processed food consumption among US adults from 2001 to 2018. American Journal of Clinical Nutrition, 115(1), 211-221. doi:10.1093/ajcn/nqab305 PMID:34590105
8. 8.Scrinis G, Monteiro CA. (2018). Ultra-processed foods and the limits of product reformulation. Public Health Nutrition, 21(1), 247-252. doi:10.1017/S1368980017001392 PMID:28625223